Skip to main content

Table 1 Comparison of DSS1 gene expression among various groups of breast cancer patients

From: Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

Clinical parameters

Group

Number of patient

DSS1gene expression median (25%, 75%)

Mann–Whitney U-test (P)

Menopause

Pre-

78

48.7 (8.05, 143)

0.554

 

Post-

210

49.2 (8.09, 92.4)

 

Nodal

(-)

179

41.2 (7.04, 94.2)

0.132

status

(+)

110

64.9 (13.2, 117)

 

Tumor

< 20

125

44.3 (8.08, 108)

0.646

size (mm)

≥ 20

164

52.2 (8.41, 104)

 

Nuclear

1

143

51.7 (8.33, 114)

0.703

grade

2

74

39.7 (8.24, 90.0)

 
 

3

72

57.5 (6.19, 91.3)

 

Vessel

(-)

187

40.0 (5.47, 88.9)

0.308

invasion

(+)

77

47.1 (11.5, 107)

 

ERα

(-)

65

52.7 (5.71, 105)

0.962

 

(+)

224

49.0 (8.36, 102)

 

PgR

(-)

96

60.3 (6.14, 103)

0.487

 

(+)

193

47.1 (8.37, 106)

 

HER2

(-)

248

53.2 (10.6, 115)

*0.0255

 

(+)

41

21.8 (3.78, 74.8)

 

Ki67

< 20

113

55.6 (16.4, 132)

**0.0096

(%)

≥ 20

169

36.0 (4.97, 82.0)

 
  1. (*) and (**) denote P < 0.05 and P < 0.01, respectively.